The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation
Abstract
Murine sclerodermatous graft-vs-host disease (Scl GVHD) models human scleroderma, with prominent skin thickening, lung fibrosis, and up-regulation of cutaneous collagen mRNA. Fibrosis in Scl GVHD may be driven by infiltrating TGF-β1-producing mononuclear cells. Here we characterize the origin and types of those cutaneous effector cells, the cytokine and chemokine environments, and the effects of anti-TGF-β Ab on skin fibrosis, immune cell activation markers, and collagen and cytokine synthesis. Donor cells infiltrating skin in Scl GVHD increase significantly at early time points post-transplantation and are detectable by PCR analysis of Y-chromosome sequences when female mice are transplanted with male cells. Cutaneous monocyte/macrophages and T cells are the most numerous cells in Scl GVHD compared with syngeneic controls. These immune cells up-regulate activation markers (MHC class II I-Ad molecules and class A scavenger receptors), suggesting Ag presentation by cutaneous macrophages in early fibrosing disease. Early elevated cutaneous mRNA expression of TGF-β1, but not TGF-β2 or TGF-β3, and elevated C-C chemokines macrophage chemoattractant protein-1, macrophage inflammatory protein-1α, and RANTES precede subsequent skin and lung fibrosis. Therefore, TGF-β1-producing donor mononuclear cells may be critical effector cells, and C-C chemokines may play important roles in the initiation of Scl GVHD. Abs to TGF-β prevent Scl GVHD by effectively blocking the influx of monocyte/macrophages and T cells into skin and by abrogating up-regulation of TGF-β1, thereby preventing new collagen synthesis. The Scl GVHD model is valuable for testing new interventions in early fibrosing diseases, and chemokines may be new potential targets in scleroderma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,272
Korngold, R., & Sprent, J. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.6.1687 · Cited by 513
Identification of Fetal DNA and Cells in Skin Lesions from Women with Systemic Sclerosis
Artlett, C. M., Smith, J. B., & Jimenez, S. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381704 · Cited by 480
Gharaee-Kermani, M., Denholm, E. M., & Phan, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17779 · Cited by 435
Transforming growth factor-beta: a general review.
Lawrence, D. A. (1996) · PubMed · Cited by 399
Evans, P. C., Lambert, N., Maloney, S., Furst, D. E., Moore, J. M., & Nelson, J. L. (1999) · Blood · doi:10.1182/blood.v93.6.2033.406k18_2033_2037 · Cited by 393
Chemokine expression in murine experimental allergic encephalomyelitis
Godiska, R., Chantry, D., Dietsch, G. N., & Gray, P. W. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00008-p · Cited by 353
McCormick, L. L., Zhang, Y., Tootell, E., & Gilliam, A. C. (1999) · PubMed · Cited by 294
Self-citationInterferon Regulatory Factor-1 Is Required for a T Helper 1 Immune Response In Vivo
Lohoff, M., Ferrick, D., Mittrücker, H.-W., Duncan, G. S., Bischof, S., Röllinghoff, M., & Mak, T. W. (1997) · Immunity · doi:10.1016/s1074-7613(00)80444-6 · Cited by 285
van der Laan, L. J. W., Döpp, E. A., Haworth, R., Pikkarainen, T., Kangas, M., Elomaa, O., Dijkstra, C. D., Gordon, S., Tryggvason, K., & Kraal, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.939 · Cited by 280
McCormick, L. L., Zhang, Y., Tootell, E., & Gilliam, A. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5693 · Cited by 265
Self-citationYamamoto, T., Eckes, B., Mauch, C., Hartmann, K., & Krieg, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6174 · Cited by 250
(2006) · Encyclopedic Reference of Immunotoxicology · doi:10.1007/3-540-27806-0_623 · Cited by 241
Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3
Eickelberg, O., Köhler, E., Reichenberger, F., Bertschin, S., Woodtli, T., Erne, P., Perruchoud, A. P., & Roth, M. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l814 · Cited by 226
Birdsall, H. H., Green, D. M., Trial, J., Youker, K. A., Burns, A. R., MacKay, C. R., LaRosa, G. J., Hawkins, H. K., Smith, C. W., Michael, L. H., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.684 · Cited by 219
Kulozik, M., Hogg, A., Lankat-Buttgereit, B., & Krieg, T. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114793 · Cited by 217
Kang, K., Hammerberg, C., Meunier, L., & Cooper, K. D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.5256 · Cited by 190
Chronic graft-versus-host disease (GVHD) as a model for scleroderma
Jaffee, B. D., & Claman, H. N. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90001-1 · Cited by 188
Kräling, B. M., Maul, G. G., & Jimenez, S. A. (1995) · Pathobiology · doi:10.1159/000163933 · Cited by 166
Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.
Wahl, S. M., Allen, J. B., Costa, G. L., Wong, H. L., & Dasch, J. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.1.225 · Cited by 155
Wang, S., LaPage, J. A., & Hirschberg, R. R. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00928.x · Cited by 145
Analysis of Macrophage Scavenger Receptor (SR-A) Expression in Human Aortic Atherosclerotic Lesions
Gough, P. J., Greaves, D. R., Suzuki, H., Häkkinen, T., Hiltunen, M. O., Turunen, M. P., Ylä‐Herttuala, S., Kodama, T., & Gordon, S. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.461 · Cited by 136
Hogaboam, C. M., Bone‐Larson, C. L., Lipinski, S., Lukacs, N. W., Chensue, S. W., Strieter, R. M., & Kunkel, S. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2193 · Cited by 132
The macrophage scavenger receptor type A directs modified proteins to antigen presentation
Nicoletti, A., Caligiuri, G., Törnberg, I., Kodama, T., Stemme, S., & Hansson, G. K. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<512::aid-immu512>3.0.co;2-y · Cited by 116
Gilliam, A. C., Kremer, I. B., Yoshida, Y., Stevens, S. R., Tootell, E., Teunissen, M. B. M., Hammerberg, C., & Cooper, K. D. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00162.x · Cited by 109
Self-citationLloyd, C. M., Dorf, M. E., Proudfoot, A. E. I., et al. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.676 · Cited by 101
Schneider, A., Panzer, U., Zahner, G., Wenzel, U. O., Wolf, G., Thaiss, F., Helmchen, U. M., & Stahl, R. A. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00543.x · Cited by 99
van der Laan, L. J. W., Kangas, M., Döpp, E. A., Broug-Holub, E., Elomaa, O., Tryggvason, K., & Kraal, G. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00077-1 · Cited by 97
Lukacs, N. W., Chensue, S. W., Smith, R. E., Strieter, R. M., Warmington, K. S., Wilke, C. A., & Kunkel, S. L. (1994) · PubMed · Cited by 95
A Possible Role for Transforming Growth Factor-β in Systemic Sclerosis
Smith, E. A., & LeRoy, E. C. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874998 · Cited by 76
Hammerberg, C., Duraiswamy, N., & Cooper, K. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5254 · Cited by 72
Abnormalities of adhesion molecules and chemokines in scleroderma
Sato, S. (1999) · Current Opinion in Rheumatology · doi:10.1097/00002281-199911000-00010 · Cited by 72
Leukocyte Migration and Activation by Murine Chemokines
Haelens, A., Wuyts, A., Proost, P., Struyf, S., Opdenakker, G., & Damme, J. V. (1996) · Immunobiology · doi:10.1016/s0171-2985(96)80019-2 · Cited by 70
Buton, X., Mamdouh, Z., Ghosh, R. N., Du, H., Kuriakose, G., Beatini, N., Grabowski, G. A., Maxfield, F. R., & Tabas, I. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32112 · Cited by 67
Lai, Z., Hundeiker, C., Gleichmann, E., & Esser, C. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.30 · Cited by 65
Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages
Umetani, N., Kanayama, Y., Okamura, M., Negoro, N., & Takeda, T. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00098-7 · Cited by 61
Black, C. M., & Stevens, W. (1989) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00983-2 · Cited by 60
Singh, N., Bhatia, S., Abraham, R. S., Basu, S. K., George, A., Bal, V., & Rath, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4869 · Cited by 57
Class A scavenger receptors and the phagocytosis of apoptotic cells
Platt, N., da Silva, R. P., & Gordon, S. (1999) · Immunology Letters · doi:10.1016/s0165-2478(98)00118-7 · Cited by 53
Widmer, U., Yang, Z., van Deventer, S. J. H., Manogue, K. R., Sherry, B. A., & Cerami, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.11.4031 · Cited by 46
Maltman, J., Pragnell, I. B., & Graham, G. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1566 · Cited by 27
Identification of a Small-Molecule, Nonpeptide Macrophage Scavenger Receptor Antagonist
Lysko, P. G., Weinstock, J., Webb, C. L., Brawner, M. E., & Elshourbagy, N. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38270-9 · Cited by 27
Murine Mφ scavenger receptor: Adhesion function and expression
Hughes, D. A., Fraser, I. P., & Gordon, S. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)00143-x · Cited by 26
Delgado‐Rizo, V., Salazar, A., Panduro, A., & Armendáriz‐Borunda, J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00111-0 · Cited by 26
Transforming Growth Factor-Beta Expression in Mouse Lung Carcinogenesis
Jakowlew, S. B., Moody, T. W., You, L., & Mariano, J. M. (1998) · Experimental Lung Research · doi:10.3109/01902149809087387 · Cited by 16
Cited by
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Chronic graft-versus-host disease
Lee, S. J., Vogelsang, G., & Flowers, M. E. D. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2003.50026 · Cited by 950
Matsunaga, T., Takemoto, N., Sato, T., Takimoto, R., Tanaka, I., Fujimi, A., Akiyama, T., Kuroda, H., Kawano, Y., Kobune, M., et al. (2003) · Nature Medicine · doi:10.1038/nm909 · Cited by 563
Inhibition of Tumor Necrosis Factor-α Reduces Atherosclerosis in Apolipoprotein E Knockout Mice
Brånén, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., & Jovinge, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143933.20616.1b · Cited by 495
Cooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., van den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.09.023 · Cited by 472
Metadata
- Authors
- Zhang, Y., McCormick, L. L., Desai, S. R., Wu, C., & Gilliam, A. C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03
- Volume
- 168
- Issue
- 6
- Pages
- 3088-3098
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1532420525
- Cited by
- 256
- References
- 49
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.